Wells Fargo lowered the firm’s price target on Colgate-Palmolive (CL) to $83 from $88 and keeps an Underweight rating on the shares. Despite an improving USD, typically a boon for Colgate-Palmolive, estimates are unchanged as the backdrop weighs, the firm says. Debates from here will be an implied sales acceleration into the second half of the year and building blocks for 2026. It is unclear if the stock gets much life pending clarity here, Wells adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target lowered to $105 from $108 at Citi
- Colgate-Palmolive: Strategic Restructuring and Innovation Drive Buy Rating
- Colgate-Palmolive Reports Modest Q2 2025 Growth
- Colgate-Palmolive’s Earnings Call: Mixed Outlook with Strategic Moves
- Colgate-Palmolive: Hold Rating Amid Challenging Market Conditions and Positive Long-Term Outlook